<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - Merck</title>
<description>International Business News - Merck</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>Merck shingles vaccine gets CDC recommendation</title>
  <description>Merck &amp; Co. said Thursday the U.S. Centers for Disease Control and Prevention has recommended that adults 60 and over be given the company's shingles vaccine Zostavax.</description>
    <link>http://www.ibtimes.com/articles/20080515/merck-shingles-vaccine-gets-cdc-recommendation.htm</link> 
  <pubDate>Thu, 15 May 2008 12:21:56 EDT</pubDate>
  </item>


  <item>
  <title>Merck, India's Ranbaxy team up to find new drugs</title>
  <description>Two of the biggest pharmaceutical companies in the United States and India are teaming up to develop new anti-infective medications. Merck &amp; Co. of Whitehouse Station, N.J., and Ranbaxy Laboratories Ltd. of Gurgaon, India, announced Monday they have signed a product development deal.</description>
    <link>http://www.ibtimes.com/articles/20080512/merck-indias-ranbaxy-team-up-to-find-new-drugs.htm</link> 
  <pubDate>Mon, 12 May 2008 10:09:34 EDT</pubDate>
  </item>


  <item>
  <title>Merck to cut 1,200 sales jobs following regulatory setback</title>
  <description>Merck &amp; Co. said Monday it is eliminating 1,200 U.S. sales jobs, a move that comes a week after federal regulators' surprise rejection of an experimental cholesterol drug heavily touted by the pharmaceutical company.</description>
    <link>http://www.ibtimes.com/articles/20080505/merck-to-cut-1-200-sales-jobs-following-regulatory-setback.htm</link> 
  <pubDate>Mon, 05 May 2008 18:01:12 EDT</pubDate>
  </item>


  <item>
  <title>Merck to cut 1,200 sales jobs following regulatory setbacks</title>
  <description>Drug developer Merck says it is cutting 1,200 sales jobs in the United States following a week of regulatory setbacks for two drug candidates. The job cuts follow Food and Drug Administration rejections for the company's proposed allergy drug combining the active ingredients of Merck's Singulair and Schering-Plough Corp.'s Claritin. The FDA also rejected the company's developing cholesterol drug Cordaptive, while publicly demanding the company clean up problems at its main vaccine plant.</description>
    <link>http://www.ibtimes.com/articles/20080505/merck-to-cut-1-200-sales-jobs-following-regulatory-setbacks.htm</link> 
  <pubDate>Mon, 05 May 2008 16:53:37 EDT</pubDate>
  </item>


  <item>
  <title>GE Healthcare licenses lung imaging technology to Merck</title>
  <description>GE Healthcare Monday said it inked an agreement with drug maker Merck &amp; Co. to provide lung imaging technology to assist in respiratory drug development.</description>
    <link>http://www.ibtimes.com/articles/20080505/ge-healthcare-licenses-lung-imaging-technology-to-merck.htm</link> 
  <pubDate>Mon, 05 May 2008 12:56:28 EDT</pubDate>
  </item>


  <item>
  <title>Streak of trouble with FDA, other problems hits Merck</title>
  <description>The roller coaster ride for Merck &amp; Co. shareholders and employees is on another speedy downhill run. In barely a week, Merck has suffered a stunning streak of setbacks, including federal regulators rejecting two experimental drugs and publicly demanding the drugmaker clean up significant problems at its main vaccine plant.</description>
    <link>http://www.ibtimes.com/articles/20080504/streak-of-trouble-with-fda-other-problems-hits-merck.htm</link> 
  <pubDate>Sun, 04 May 2008 13:41:44 EDT</pubDate>
  </item>


  <item>
  <title>Merck extends deadline for Vioxx registrants to submit proof</title>
  <description>While asserting that the proposed $4.85 billion settlement for illness associated with Vioxx remains on track, the painkiller's manufacturer on Thursday extended until June 30 the deadline for registered participants to submit paperwork.</description>
    <link>http://www.ibtimes.com/articles/20080501/merck-extends-deadline-for-vioxx-registrants-to-submit-proof.htm</link> 
  <pubDate>Thu, 01 May 2008 18:52:20 EDT</pubDate>
  </item>


  <item>
  <title>FDA warns Merck to clean up violations at vaccine plant</title>
  <description>The Food and Drug Administration is warning drugmaker Merck &amp; Co. to fix problems at its main vaccine plant. The agency on Wednesday released a warning letter sent to Merck's chief executive that says FDA inspectors determined manufacturing rules are not being followed at the plant in West Point, Pa., just outside Philadelphia.</description>
    <link>http://www.ibtimes.com/articles/20080430/fda-warns-merck-to-clean-up-violations-at-vaccine-plant.htm</link> 
  <pubDate>Wed, 30 Apr 2008 11:58:32 EDT</pubDate>
  </item>


  <item>
  <title>FDA warns Merck to fix vaccine plant problems</title>
  <description>The Food and Drug Administration is warning drugmaker Merck &amp; Co. to fix problems at its main vaccine plant. The agency on Wednesday released a warning letter sent to Merck's chief executive that says FDA inspectors determined manufacturing rules are not being followed at the plant in West Point, Pa., just outside Philadelphia.</description>
    <link>http://www.ibtimes.com/articles/20080430/fda-warns-merck-to-fix-vaccine-plant-problems.htm</link> 
  <pubDate>Wed, 30 Apr 2008 11:41:39 EDT</pubDate>
  </item>


  <item>
  <title>Merck shares fall on FDA drug rejection, Abbott shares rise</title>
  <description>Merck &amp; Co. shares fell Tuesday after the Food and Drug Administration rejected the drugmaker's cholesterol drug Cordaptive, marking the company's second drug application rejection in four days.</description>
    <link>http://www.ibtimes.com/articles/20080429/merck-shares-fall-on-fda-drug-rejection-abbott-shares-rise.htm</link> 
  <pubDate>Tue, 29 Apr 2008 18:56:01 EDT</pubDate>
  </item>


  <item>
  <title>U.S. Stocks Retreat Ahead of Fed Announcement</title>
  <description>Shares of pharmaceutical giant Merck put pressure on the Dow, after losing 10 percent as the Food and Drug Administration rejected its cholesterol drug Cordaptive, one of the key drugs in its pipeline.</description>
    <link>http://www.ibtimes.com/articles/20080429/stocks-merck-fed-markets-earnings.htm</link> 
  <pubDate>Tue, 29 Apr 2008 17:25:16 EDT</pubDate>
  </item>


  <item>
  <title>Merck stock plunges after FDA rejects key cholesterol drug</title>
  <description>Stock in drugmaker Merck &amp; Co. plunged as analysts warned investors Tuesday to expect lower revenues and share prices, a day after the Food &amp; Drug Administration rejected an experimental Merck drug for the second time in four days.</description>
    <link>http://www.ibtimes.com/articles/20080429/merck-stock-plunges-after-fda-rejects-key-cholesterol-drug.htm</link> 
  <pubDate>Tue, 29 Apr 2008 14:53:20 EDT</pubDate>
  </item>


  <item>
  <title>Premarket Roundup: Merck, First Horizon</title>
  <description>Among the premarket stories for Tuesday, April 29, from AP Financial News: NEW YORK (AP) _ An analyst cut a price target on Merck &amp; Co. Tuesday, the day after the Food &amp; Drug Administration rejected an experimental drug that would have boosted the company's cholesterol franchise.</description>
    <link>http://www.ibtimes.com/articles/20080429/premarket-roundup-merck-first-horizon.htm</link> 
  <pubDate>Tue, 29 Apr 2008 09:24:28 EDT</pubDate>
  </item>


  <item>
  <title>Ahead of the Bell: Merck price target cut after FDA denial</title>
  <description>An analyst cut a price target on Merck &amp; Co. Tuesday, the day after the Food &amp; Drug Administration rejected an experimental drug that would have boosted the company's cholesterol franchise.</description>
    <link>http://www.ibtimes.com/articles/20080429/ahead-of-the-bell-merck-price-target-cut-after-fda-denial.htm</link> 
  <pubDate>Tue, 29 Apr 2008 07:36:45 EDT</pubDate>
  </item>


  <item>
  <title>FDA seeks more information from Merck for cholesterol drug</title>
  <description>Merck &amp; Co. says the Food and Drug Administration needs more information on its cholesterol drug candidate, but the pharmaceutical company reaffirmed its profit guidance despite the setback.</description>
    <link>http://www.ibtimes.com/articles/20080428/fda-seeks-more-information-from-merck-for-cholesterol-drug.htm</link> 
  <pubDate>Mon, 28 Apr 2008 18:27:19 EDT</pubDate>
  </item>


  <item>
  <title>Newspaper: FDA found concerns at Merck vaccine plant</title>
  <description>Contaminated children's vaccines and other potentially serious concerns were spotted by federal regulators who combed Merck &amp; Co.'s vaccine plant in the Philadelphia suburbs, according to a published report.</description>
    <link>http://www.ibtimes.com/articles/20080424/newspaper-fda-found-concerns-at-merck-vaccine-plant.htm</link> 
  <pubDate>Thu, 24 Apr 2008 18:21:34 EDT</pubDate>
  </item>


  <item>
  <title>Free of buyout costs Merck swings to profit in Q1 on sales</title>
  <description>German drug maker Merck KGaA said Wednesday it swung to a profit in the first quarter on an 8.3 percent rise in revenue, compared with the same period last year when its buyout of a Swiss biotechnology company led to a loss.</description>
    <link>http://www.ibtimes.com/articles/20080423/free-of-buyout-costs-merck-swings-to-profit-in-q1-on-sales.htm</link> 
  <pubDate>Wed, 23 Apr 2008 09:53:10 EDT</pubDate>
  </item>


  <item>
  <title>Earnings roundup: Merck, Eli Lilly</title>
  <description>Among the earnings stories for Monday, April 21, from the AP Financial Desk: Top stories:</description>
    <link>http://www.ibtimes.com/articles/20080421/earnings-roundup-merck-eli-lilly.htm</link> 
  <pubDate>Mon, 21 Apr 2008 10:35:55 EDT</pubDate>
  </item>


  <item>
  <title>Merck profit almost doubles in 1Q on gain; sales edge up</title>
  <description>The drugmaker Merck &amp; Co. says its profit almost doubled in the first quarter due to a $1.4 billion distribution from a partner drug company. It sales were slightly higher.</description>
    <link>http://www.ibtimes.com/articles/20080421/merck-profit-almost-doubles-in-1q-on-gain-sales-edge-up.htm</link> 
  <pubDate>Mon, 21 Apr 2008 08:08:05 EDT</pubDate>
  </item>


  <item>
  <title>Merck could face tough 1Q on Vytorin, Singulair concerns</title>
  <description>
Merck &amp; Co. reports earnings for the first quarter on Monday. The following is a summary of key developments and analyst opinion related to the period.

OVERVIEW: The company's cholesterol drug fran...</description>
    <link>http://www.ibtimes.com/articles/20080418/merck-could-face-tough-1q-on-vytorin-singulair-concerns.htm</link> 
  <pubDate>Fri, 18 Apr 2008 13:08:51 EDT</pubDate>
  </item>


</channel>
</rss>